APA (7th ed.) Citation

MR, S., H, L., F, M., MA, F., M, G., AL, Z., & JS, F. (2008). Metabolic changes during gonadotropin-releasing hormone agonist therapy for prostate cancer: Differences from the classic metabolic syndrome. Cancer, 112(10), 2188. https://doi.org/10.1002/cncr.23440

Chicago Style (17th ed.) Citation

MR, Smith, Lee H, McGovern F, Fallon MA, Goode M, Zietman AL, and Finkelstein JS. "Metabolic Changes During Gonadotropin-releasing Hormone Agonist Therapy for Prostate Cancer: Differences from the Classic Metabolic Syndrome." Cancer 112, no. 10 (2008): 2188. https://doi.org/10.1002/cncr.23440.

MLA (9th ed.) Citation

MR, Smith, et al. "Metabolic Changes During Gonadotropin-releasing Hormone Agonist Therapy for Prostate Cancer: Differences from the Classic Metabolic Syndrome." Cancer, vol. 112, no. 10, 2008, p. 2188, https://doi.org/10.1002/cncr.23440.